Pharmaceuticals stocks with fastest growth in sales
| Company | CMP (Rs) | Sales CAGR (3 yrs, %) | Profit CAGR (3 yrs, %) | MCap (Rs m) | D/E (Curr FY, x) | P/E (x) | P/BV (x) |
|---|---|---|---|---|---|---|---|
| GUJ.INJ(KER) | 19.1 | 694.3% | NM | 280 | 0.0 | 36.1 | 2.9 |
| TOHEAL PHARMA | 152.5 | 241.2% | 1,086.2% | 3,733 | 0.4 | NM | 14.3 |
| ACHYUT HEALTHCARE | 67.0 | 182.3% | 277.9% | 1,127 | 0.0 | NM | 3.7 |
| SWAGRUHA INFRA | 3.5 | 131.4% | 141.4% | 236 | 0.1 | NM | 3.1 |
| FERVENT SYNERGIES | 15.7 | 122.4% | NM | 470 | 0.0 | NM | 1.5 |
| WALPAR NUTRITIONS LTD. | 46.5 | 117.6% | 135.0% | 437 | 0.6 | NM | 2.3 |
| FABINO LIFE | 28.0 | 90.3% | 5.9% | 59 | 0.3 | NM | 1.4 |
| RELISH PHARMA | 58.3 | 88.2% | 361.9% | 2,552 | 0.1 | 17.7 | 4.7 |
| DIPNA PHARMACHEM | 6.5 | 74.4% | 255.3% | 157 | 0.5 | NM | 0.4 |
| TRIDENT LIFELINE | 290.0 | 66.8% | 111.0% | 3,335 | 0.4 | 42.8 | 6.0 |
| VASA DENTICITY | 637.5 | 62.5% | 259.0% | 10,431 | 0.0 | NM | 10.9 |
| CHANDRA BHAGAT PHARMA | 69.0 | 46.3% | 100.5% | 521 | 0.6 | NM | 1.9 |
| YATHARTH HOSPITAL | 616.0 | 43.1% | 80.1% | 52,880 | 0.1 | 40.9 | 5.6 |
| VIVANZA BIOSCIENCES | 4.0 | 41.2% | 93.7% | 162 | 1.1 | 227.6 | 3.3 |
| QUEST LABORATORIES LTD. | 115.0 | 39.6% | 148.9% | 1,885 | 0.2 | NM | 2.6 |
| INDEGENE LTD. | 639.7 | 38.9% | 21.9% | 153,048 | 0.3 | NM | 6.5 |
| INNOVA CAPTAB LTD. | 991.4 | 38.1% | 39.8% | 56,730 | 0.3 | 47.9 | 6.2 |
| FREDUN PHARMA | 690.0 | 37.5% | 97.9% | 3,258 | 0.9 | 18.4 | 2.4 |
| SHREE GANESH REMEDIES | 670.0 | 36.9% | 42.3% | 8,601 | 0.3 | 30.2 | 6.5 |
| BETA DRUGS | 1,440.4 | 36.6% | 45.9% | 13,848 | 0.1 | NM | 12.1 |
| ROOPA INDUSTRIES | 79.1 | 35.0% | 28.5% | 622 | 1.7 | 39.4 | 3.8 |
| JEENA SIKHO | 1,945.0 | 33.7% | 88.7% | 48,353 | 0.0 | NM | 25.0 |
| RUBRA MEDICA | 13.3 | 32.6% | 75.3% | 73 | 0.0 | NM | 14.1 |
| S.S.ORGANICS | 67.4 | 31.2% | NM | 2,493 | -1.5 | 11,330.4 | NM |
| KILITCH DRUGS | 300.0 | 31.1% | 53.3% | 4,825 | 0.2 | 34.1 | 2.6 |
* We show NM where the values are negative
Disclaimer: This is for information purposes only. These are not stock recommendations and should not be treated as such. Learn more about our recommendation services here... Also note that these screeners are based only on numbers. There is no screening for management quality.
Equitymaster's powerful BSE/NSE Stock Screener allows you to screen stocks based on both pre-set and your own criteria.